Physician profile
Suzanne Bartman
NPI 1104492271
$16,974.00
in general payments reported to CMS, 2019-2025
12 companies · $8,879 in 2025
The $8,879 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $131 · 2022: $161 · 2023: $3,846 · 2024: $3,957 · 2025: $8,879.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,358 · Travel and Lodging: $4,515 · Consulting Fee: $4,000 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $700 · Education: $108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,358.46 |
| Travel and Lodging | $4,515.43 |
| Consulting Fee | $4,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $700.00 |
| Education | $108.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $6,709.59 | 2023-2025 | Corevalve Evolut R |
| Abbott Laboratories | $5,571.35 | 2025 | Navitor |
| Boston Scientific Corporation | $1,847.92 | 2023-2024 | Watchman Flx, Avvigo Guidance System, Accolade Sr |
| Edwards Lifesciences Corporation | $1,691.32 | 2021-2025 | Sapien 3 Ultra Resilia, Pascal, Inspiris Resilia Aortic Valve |
| W. L. Gore & Associates, INC. | $446.86 | 2023-2024 | Gore Cardioform Septal Occluder |
| Abiomed | $344.22 | 2024-2025 | Impella |
| Cardiva Medical, INC. | $150.55 | 2024 | Savvywire |
| Heartflow, INC. | $130.35 | 2025 | |
| Atricure, INC. | $26.19 | 2025 | Atriclip Laa Exclusion System, Synergy Ablation System, Atricure Cryoice Cryoablation System (Cryo2) |
| La Jolla Pharmaceutical Company | $19.59 | 2024 | Giapreza |
| Solventum Corporation | $18.45 | 2025 | Activ.A.C. |
| Chiesi USA, INC. | $17.61 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Bartman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.